| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 32,5 M € | +6.5% | 30,5 M € | +7.4% | 28,4 M € | -1.7% | 28,9 M € | +30.9% | 22,1 M € | +16.8% | 18,9 M € | +10.0% | 17,2 M € | +2.2% | 16,8 M € | +7.1% | 15,7 M € | +1.2% | 15,5 M € | +2.9% | 15,1 M € | +0.8% | 15,0 M € | -0.8% | 15,1 M € | +2.4% | 14,8 M € | +0.9% | 14,6 M € | +0.1% | 14,6 M € | +0.1% | 14,6 M € | -46.0% | 27,1 M € | |
| EBITDA | 1,4 M € | +41.3% | 1,0 M € | +39.1% | 736,3 k € | +35.4% | 543,7 k € | +124.8% | 241,8 k € | -52.3% | 507,4 k € | -43.0% | 890,4 k € | -6.4% | 950,8 k € | +3.5% | 919,1 k € | +3.4% | 889,2 k € | +1.2% | 878,8 k € | +43.1% | 614,4 k € | +22.1% | 503,2 k € | -20.8% | 635,2 k € | -2.8% | 653,6 k € | +16.7% | 559,8 k € | -5.7% | 593,5 k € | +24.5% | 476,6 k € | |
| Operating profit | 1,1 M € | +91.8% | 559,2 k € | +83.0% | 305,6 k € | +148.7% | 122,9 k € | +138.4% | -320,2 k € | -680.6% | -41,0 k € | -112.8% | 320,3 k € | +11.1% | 288,4 k € | -20.1% | 360,8 k € | +40.3% | 257,3 k € | +10.1% | 233,7 k € | +189.3% | 80,8 k € | -12.6% | 92,4 k € | -67.9% | 287,6 k € | -15.7% | 341,1 k € | +64.4% | 207,5 k € | +1.1% | 205,3 k € | -13.7% | 238,0 k € | |
| Profit/loss | 787,1 k € | +82.0% | 432,4 k € | +61.4% | 267,8 k € | +66.6% | 160,7 k € | +167.8% | -237,0 k € | -773.8% | 35,2 k € | -87.8% | 288,1 k € | +10.3% | 261,2 k € | +22.1% | 213,9 k € | +52.0% | 140,7 k € | -88.3% | 1,2 M € | +832.1% | 129,2 k € | +12.3% | 115,1 k € | -63.6% | 316,2 k € | -20.8% | 399,5 k € | -35.6% | 620,2 k € | +95.1% | 317,8 k € | +6.9% | 297,2 k € | |
| Equity | 5,1 M € | -32.5% | 7,5 M € | -8.6% | 8,2 M € | +2.2% | 8,1 M € | +1.6% | 7,9 M € | -2.9% | 8,2 M € | +0.2% | 8,1 M € | +1.6% | 8,0 M € | +3.9% | 7,7 M € | +2.9% | 7,5 M € | +1.9% | 7,4 M € | -14.5% | 8,6 M € | +1.5% | 8,5 M € | +1.4% | 8,4 M € | +3.9% | 8,1 M € | +4.4% | 7,7 M € | +8.7% | 7,1 M € | -8.1% | 7,7 M € | |
| Total assets | 9,5 M € | -15.3% | 11,2 M € | -2.9% | 11,5 M € | +7.3% | 10,8 M € | -12.6% | 12,3 M € | +10.3% | 11,1 M € | -0.8% | 11,2 M € | -2.1% | 11,5 M € | +1.8% | 11,3 M € | -2.2% | 11,5 M € | -4.1% | 12,0 M € | -7.8% | 13,0 M € | +6.6% | 12,2 M € | +3.4% | 11,8 M € | +21.3% | 9,7 M € | +4.8% | 9,3 M € | -7.6% | 10,1 M € | -6.5% | 10,8 M € | |
| Cash | 994,1 k € | -17.0% | 1,2 M € | -21.2% | 1,5 M € | +301.8% | 378,2 k € | -25.5% | 507,8 k € | -22.8% | 657,6 k € | -48.0% | 1,3 M € | -15.9% | 1,5 M € | -15.9% | 1,8 M € | -0.3% | 1,8 M € | +304.6% | 443,5 k € | -58.7% | 1,1 M € | +36.5% | 786,0 k € | -56.8% | 1,8 M € | +86.6% | 975,2 k € | +53.0% | 637,5 k € | +18.5% | 538,1 k € | +4.6% | 514,6 k € | |
| Debts | 4,4 M € | +19.9% | 3,7 M € | +11.2% | 3,3 M € | +22.6% | 2,7 M € | -37.9% | 4,4 M € | +46.7% | 3,0 M € | -3.9% | 3,1 M € | -10.5% | 3,5 M € | -2.6% | 3,5 M € | -11.7% | 4,0 M € | -13.7% | 4,7 M € | +5.5% | 4,4 M € | +18.3% | 3,7 M € | +9.5% | 3,4 M € | +103.5% | 1,7 M € | +9.7% | 1,5 M € | -46.7% | 2,9 M € | -3.6% | 3,0 M € | |
| Staff | 60,2 | 59,4 | 62,4 | 62,5 | 54,5 | 47,7 | 44,6 | 44,3 | 36,3 | 36 | 36 | 36,1 | 33,9 | 34,1 | 35,2 | 35,6 | 35,6 | 34,4 | ||||||||||||||||||
Public limited company · Beernem · incorporated on 01/10/1979 · 60,2 ETP
Public limited company profitable and well capitalised. Cash position declining (-17.0%).
Solid counterparty for a standard engagement.
APOTHEEK DESSEIN is a Public limited company incorporated in 1979. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Beernem. It employs on average 60,2 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette